LCD L38284: MolDX: Predictive Classifiers for Early Stage Non-small Cell Lung Cancer — CGS
Policy LCD-L38284 · Oncology
New billing rules for lung cancer predictive classifiers effective 2025.
Code intelligence
Z85.118 reimbursement alerts
Policy changes, MAC LCD updates, and CMS guidance matched to code Z85.118.
Normal code riskView ICD-10 detail
Signal breakdown
3 shown · 3 total in platform
Risk: Normal
0
Critical
0%
0
High
0%
3
Routine
100%
0
Low
0%
New this month
—
alerts added in last 30 days
Effective soon
—
no upcoming deadlines
Routine
LCD L37897: MolDX: Inivata™, InVisionFirst®, Liquid Biopsy for Patients with Lung Cancer — Noridian
Policy LCD-L37897 · Oncology
New liquid biopsy tests for lung cancer impact billing.
LCD L37899: MolDX: Inivata™, InvisionFirst®, Liquid Biopsy for Patients with Lung Cancer — Noridian
Policy LCD-L37899 · Oncology
New liquid biopsy tests for lung cancer impact billing.
Audit documentation
Building an audit file that includes Z85.118?
The Tripwire Audit Pack exports 12 months of Oncology policy-change history — every alert with a link to its government source document, as a formatted PDF for compliance distribution plus a machine-readable CSV. Delivered automatically after payment. No account, no call.
Get the Oncology audit pack — $349One-time purchase · not a subscription